Back to Research Home
HUMHumana Inc
Health Care · Managed Health Care · Large
$422.07+0.26%
As of 23 Oct 2026Mkt cap $48.1B
Stage 13
AVOID
Fundamentals
29.6/75
Technical
6.7/15
Independent
36.3/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +11.0%
- 3M
- +10.7%
- 6M
- +96.1%
- 1Y
- +46.7%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 39.8xHist median 24.2x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 26.2x
- FCF yield
- 3.8%
Quality
- ROIC
- 8.6%
- Operating margin
- 2.2%
- FCF margin
- 0.3%
- Current ratio
- 2.0x
Growth
- Revenue growth
- +10.1%Latest FY YoY
- Revenue CAGR
- +11.8%
- EPS CAGR
- −18.8%
- FCF CAGR
- −20.1%
Capital
- Share-count trend
- −1.5%3Y annualised
- Net debt
- $8.7B9.5x OCF
Annual trend
- CAGR 2021–2025
- +11.8%
- Latest · 2025
- $130B
- YoY
- +10.1%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-06
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- extended
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded